PB 153 of 2025
National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2025 (No. 12)
I, ALEX DOYLE, Assistant Secretary (Acting), PBS Listing, Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, Disability and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 23 December 2025
ALEX DOYLE
Assistant Secretary (Acting)
PBS Listing, Pricing and Policy Branch
Technology Assessment and Access Division
Contents
1. Name
2. Commencement
3. Authority
4. Schedules
Schedule 1—Amendments
National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)
1. Name
(1) This instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2025 (No. 12).
(2) This instrument may also be cited as PB 153 of 2025.
2. Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information |
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 January 2026 | 1 January 2026 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3. Authority
This instrument is made under subsection 84AAA(2) of the National Health Act 1953.
4. Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.